14. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S (2006) Steroid and
xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular
matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem
281: 16927-16934.
15. Deurveilher S, Cumyn EM, Peers T, Rusak B, Semba K (2008) Estradiol replacement
enhances sleep deprivation-induced c-Fos immunoreactivity in forebrain arousal
regions of ovariectomized rats. Am J Physiol Regul Integr Comp Physiol. epub (Aug
2008); doi:10.1152/ajpregu.90576.2008.
16. Wang Q, Li X, Wang L, Feng YH, Zeng R, Gorodeski G. (2004) Antiapoptotic effects
of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145:
5568-5579.
17. Wise PM, Dubal DB, Wilson ME, Rau SW, Böttner M (2001) Minireview:
neuroprotective effects of estrogen—new insights into mechanisms of action.
Endocrinology 142: 969-973.
18. Gonzales KL, Tetel MJ, Wagner CK (2008) Estrogen receptor (ER) β modulates ERα
responses to estrogens in the developing rat ventromedial nucleus of the
hypothalamus. Endocrinology 149: 4615-4621.
19. Simpson ER, Davis SR (2001) Minireview: aromatase and the regulation of estrogen
biosynthesis—some new perspectives. Endocrinology 142: 4589-4594.
20. Rotwein P, Burgess SK, Milbrandt JD, Krause JE (1988) Differential expression of
insulin-like growth factor genes in rat central nervous system, Proc Natl Acad Sci
USA 85: 265–269.
21. Leventhal PS, Russell JW, Feldman EL (1999) IGFs and the nervous system. In:
Rosefeld RG and Roberts CT (ed) The IGF System. Humana Press. New Jersey:
425-455.
22. Couce ME, Weatherington AJ, McGinty JF (1992) Expression of insulin-like growth
factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptor in the rat hippocampus:
an in situ hybridization and immunocytochemical study. Endocrinology 131:
1636-1642.
23. Chesik D, De Keyser J, Wilczak N (2007) Insulin-like growth factor binding
protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis.
Cytokine Growth Factor Rev 18: 267-278.
24. Ocrant I, Fay CT, Parmelee JT (1990) Characterization of insulin-like growth factor
binding proteins produced in the rat central nervous system. Endocrinology 127:
1260-1267.
25. Arai T, Busby WJ, Clemmons DR (1996) Binding of insulin-like growth factor
(IGF-I) or II to IGF-binding protein-2 enables it to bind to heparin and extracellular
matrix. Endocrinology 137 :4571–4575
26. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR,
de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and
signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers
Dis 7: 63-80.
27. Messier C and Teutenberg K (2005) The role of insulin, insulin growth factor, and
insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 12:
311-328.
28. Azcoitia I, Sierra A, Garcia-Segura LM (1999) Neuroprotective effects of estradiol in
the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J
Neurosci Res 58: 815-822.
29. Fox MA, Alexander JK, Afshari FS, Colello RJ, Fuss B (2004) Phosphodiesterase-I
alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during
myelination. Mol Cell Neurosci 27: 140-150.
